Cargando…
Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents
Due to their manifold biological activities, natural products such as triterpenoids have advanced to represent excellent leading structures for the development of new drugs. For this reason, we focused on the syntheses and cytotoxic evaluation of derivatives obtained from gypsogenin, hederagenin, an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026082/ https://www.ncbi.nlm.nih.gov/pubmed/35457180 http://dx.doi.org/10.3390/ijms23084362 |
_version_ | 1784691036149252096 |
---|---|
author | Kraft, Oliver Hartmann, Ann-Kathrin Hoenke, Sophie Serbian, Immo Csuk, René |
author_facet | Kraft, Oliver Hartmann, Ann-Kathrin Hoenke, Sophie Serbian, Immo Csuk, René |
author_sort | Kraft, Oliver |
collection | PubMed |
description | Due to their manifold biological activities, natural products such as triterpenoids have advanced to represent excellent leading structures for the development of new drugs. For this reason, we focused on the syntheses and cytotoxic evaluation of derivatives obtained from gypsogenin, hederagenin, and madecassic acid, cytotoxicity increased—by and large—from the parent compounds to their acetates. Another increase in cytotoxicity was observed for the acetylated amides (phenyl, benzyl, piperazinyl, and homopiperazinyl), but a superior cytotoxicity was observed for the corresponding rhodamine B conjugates derived from the (homo)-piperazinyl amides. In particular, a madecassic acid homopiperazinyl rhodamine B conjugate 24 held excellent cytotoxicity and selectivity for several human tumor cell lines. Thus, this compound was more than 10,000 times more cytotoxic than parent madecassic acid for A2780 ovarian cancer cells. We assume that the presence of an additional hydroxyl group at position C–6 in derivatives of madecassic, as well as the (2α, 3β) configuration of the acetates in ring A, had a beneficial effect onto the cytotoxicity of the conjugates, as well as onto tumor/non-tumor cell selectivity. |
format | Online Article Text |
id | pubmed-9026082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90260822022-04-23 Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents Kraft, Oliver Hartmann, Ann-Kathrin Hoenke, Sophie Serbian, Immo Csuk, René Int J Mol Sci Article Due to their manifold biological activities, natural products such as triterpenoids have advanced to represent excellent leading structures for the development of new drugs. For this reason, we focused on the syntheses and cytotoxic evaluation of derivatives obtained from gypsogenin, hederagenin, and madecassic acid, cytotoxicity increased—by and large—from the parent compounds to their acetates. Another increase in cytotoxicity was observed for the acetylated amides (phenyl, benzyl, piperazinyl, and homopiperazinyl), but a superior cytotoxicity was observed for the corresponding rhodamine B conjugates derived from the (homo)-piperazinyl amides. In particular, a madecassic acid homopiperazinyl rhodamine B conjugate 24 held excellent cytotoxicity and selectivity for several human tumor cell lines. Thus, this compound was more than 10,000 times more cytotoxic than parent madecassic acid for A2780 ovarian cancer cells. We assume that the presence of an additional hydroxyl group at position C–6 in derivatives of madecassic, as well as the (2α, 3β) configuration of the acetates in ring A, had a beneficial effect onto the cytotoxicity of the conjugates, as well as onto tumor/non-tumor cell selectivity. MDPI 2022-04-14 /pmc/articles/PMC9026082/ /pubmed/35457180 http://dx.doi.org/10.3390/ijms23084362 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kraft, Oliver Hartmann, Ann-Kathrin Hoenke, Sophie Serbian, Immo Csuk, René Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents |
title | Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents |
title_full | Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents |
title_fullStr | Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents |
title_full_unstemmed | Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents |
title_short | Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents |
title_sort | madecassic acid—a new scaffold for highly cytotoxic agents |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026082/ https://www.ncbi.nlm.nih.gov/pubmed/35457180 http://dx.doi.org/10.3390/ijms23084362 |
work_keys_str_mv | AT kraftoliver madecassicacidanewscaffoldforhighlycytotoxicagents AT hartmannannkathrin madecassicacidanewscaffoldforhighlycytotoxicagents AT hoenkesophie madecassicacidanewscaffoldforhighlycytotoxicagents AT serbianimmo madecassicacidanewscaffoldforhighlycytotoxicagents AT csukrene madecassicacidanewscaffoldforhighlycytotoxicagents |